Patient Study

The ASCO Post Publishes Multiple Perspectives on Outcome of ODAC Meeting ... - AUTO-MOBI.info (press release)
( Fri, 03 Sep 2010 10:05:08 GMT+00:00 )

The ASCO Post Publishes Multiple Perspectives on Outcome of ODAC Meeting ...
AUTO-MOBI.info (press release)
Joanne Mortimer, MD, a member of ODAC, who voted to approve bevacizumab in advanced breast cancer in December 2007 based on the E2100 study, said, ...

and more »

Celldex Therapeutics Regains Worldwide Rights to Rindopepimut (CDX-110) - DigitalJournal.com (press release)
( Fri, 03 Sep 2010 11:05:31 GMT+00:00 )

Celldex Therapeutics Regains Worldwide Rights to Rindopepimut (CDX-110)
DigitalJournal.com (press release)
"Rindopepimut is widely perceived by clinicians as one of the most promising non-toxic drug candidates for a patient population that has very limited ...

and more »

Serendipity contributes to MRSA susceptibility findings - Science Centric
( Fri, 03 Sep 2010 10:45:44 GMT+00:00 )

Serendipity contributes to MRSA susceptibility findings
Science Centric
The researchers uncovered important genetic clues that ultimately could help inform patient management and drug development. 'If you know up front that a ...

and more »

Salmonella Gastroenteritis Outbreak After a Reception --- Connecticut, 2009 - Food Consumer
( Fri, 03 Sep 2010 10:47:02 GMT+00:00 )

Salmonella Gastroenteritis Outbreak After a Reception --- Connecticut, 2009
Food Consumer
The stool sample from the index case-patient was collected on September 14 and processed at a private laboratory; the clinical isolate was then sent to the ...

Agennix AG Announces Data From Talactoferrin Randomized, Double-Blind, Placebo ... - Trading Markets (press release)
( Fri, 03 Sep 2010 08:02:15 GMT+00:00 )

Agennix AG Announces Data From Talactoferrin Randomized, Double-Blind, Placebo ...
Trading Markets (press release)
... sepsis while being well tolerated in this very sick patient population. These results warrant additional study of talactoferrin to treat this condition. ...

and more »

Cardiogenesis Comments On The STAR-Heart Study Presented At European Society ... - Medical News Today (press release)
( Fri, 03 Sep 2010 11:02:03 GMT+00:00 )

Cardiogenesis Comments On The STAR-Heart Study Presented At European Society ...
Medical News Today (press release)
Although our clinical studies testing delivery of stem cells with the PHOENIX Combination Delivery System will target different patient populations than ...

and more »

In The Margins: State leaders must clarify hazy Medical Marihuana Act - MLive.com
( Fri, 03 Sep 2010 09:43:51 GMT+00:00 )

In The Margins: State leaders must clarify hazy Medical Marihuana Act
MLive.com
These establishments from dispensaries to patient and caregiver clubs to medical marijuana schools could either pump thousands into the local economy or ...

and more »

Preventive surgery protects against breast, ovarian cancer in women carrying ... - News-Medical.net
( Fri, 03 Sep 2010 11:37:55 GMT+00:00 )

Preventive surgery protects against breast, ovarian cancer in women carrying ...
News-Medical.net
... is one of the study's co-authors. "These findings should help women with these mutations and their doctors select strategies to reduce a patient's ...

and more »

Ethical Obligation for Restricting the Number of Embryos Transferred to Women ... - Medscape
( Fri, 03 Sep 2010 08:08:26 GMT+00:00 )

Ethical Obligation for Restricting the Number of Embryos Transferred to Women ...
Medscape
Patient attitudes towards twin pregnancies and single embryo transfera questionnaire study. Hum Reprod 2007;22(10): 26732678 Murray S, Shetty A, ...

Celldex Therapeutics Regains Worldwide Rights to Rindopepimut (CDX-110) - istockAnalyst.com (press release)
( Fri, 03 Sep 2010 11:08:38 GMT+00:00 )

Celldex Therapeutics Regains Worldwide Rights to Rindopepimut (CDX-110)
istockAnalyst.com (press release)
"Rindopepimut is widely perceived by clinicians as one of the most promising non-toxic drug candidates for a patient population that has very limited ...

and more »

Celldex Therapeutics Regains Worldwide Rights to Rindopepimut (CDX-110) - Trading Markets (press release)
( Fri, 03 Sep 2010 11:14:52 GMT+00:00 )

Celldex Therapeutics Regains Worldwide Rights to Rindopepimut (CDX-110)
Trading Markets (press release)
"Rindopepimut is widely perceived by clinicians as one of the most promising non-toxic drug candidates for a patient population that has very limited ...

and more »

Patients claim a postcode lottery for drug - East Anglian Daily Times
( Fri, 03 Sep 2010 08:13:52 GMT+00:00 )

East Anglian Daily Times

Patients claim a postcode lottery for drug
East Anglian Daily Times
NHS Suffolk claim GPs cannot prescribe Sativex, to MS sufferers but it can be accessed with the approval of a patient's neurologist. ...

Celldex Therapeutics Regains Worldwide Rights to Rindopepimut (CDX-110) - MarketWatch (press release)
( Fri, 03 Sep 2010 11:07:09 GMT+00:00 )

Celldex Therapeutics Regains Worldwide Rights to Rindopepimut (CDX-110)
MarketWatch (press release)
"Rindopepimut is widely perceived by clinicians as one of the most promising non-toxic drug candidates for a patient population that has very limited ...

and more »

Cardiogenesis Corporation releases comment on STAR-heart study - News-Medical.net
( Fri, 03 Sep 2010 11:48:04 GMT+00:00 )

Cardiogenesis Corporation releases comment on STAR-heart study
News-Medical.net
Although our clinical studies testing delivery of stem cells with the PHOENIX Combination Delivery System will target different patient populations than ...

and more »

Rochester leads international effort to improve muscular dystrophy treatment - Genetic Engineering News (press release)
( Fri, 03 Sep 2010 11:54:33 GMT+00:00 )

Rochester leads international effort to improve muscular dystrophy treatment
Genetic Engineering News (press release)
With today's best treatments, the disease, which affects about 28000 boys and young men in the United States, is often fatal by the time a patient reaches ...

Celldex Therapeutics Regains Worldwide Rights to Rindopepimut (CDX-110) - Benzinga
( Fri, 03 Sep 2010 11:19:25 GMT+00:00 )

Celldex Therapeutics Regains Worldwide Rights to Rindopepimut (CDX-110)
Benzinga
"Rindopepimut is widely perceived by clinicians as one of the most promising non-toxic drug candidates for a patient population that has very limited ...

and more »

Complete the Form Below
and Unlock Your
Mobile Phone instantly!

Name

Email

Mobile/Cell Phone

How did you find us

uncertaintymusic.info		Home Contact Us